Allegra Orthopaedics Limited provides the following update: Due to the global impact of the COVID-19 pandemic, including restrictions on international travel, Allegra has had to delay the implantation of the last group of sheep in Lyon France. This implantation was part of the preclinical large animal study for the cervical fusion device being undertaken. Allegra has utilized the time provided by this delay as an opportunity to implement recent advancements in 3D printing technology, therefore allowing the implant design to be enhanced. Fractures of the implants were observed during the 6-months study. As the design of the device is based on forces in the human spine, the main root cause of the fractures was associated with the animal model. More specifically, the neck mobility and the domed shape of the sheep cervical intervertebral disc and the contact pressures of the spinal joint are significantly different to human cervical spine. Hence the revised design will improve the strength of the implant significantly and allow for the physiological differences in the animal model. Subject to any further delays imposed by COVID-19, Allegra expects to continue with the study and implant the last set of animals with the improved implant design in January 2021 As a consequence, the small confirmatory human clinical trial in Australia, being the final step before commercialisation, will also be delayed.